Neola Medical’s Q4 report presentation hosted by Investor Studios
Catch up on the highlights from Neola Medical’s year-end Q4 report for 2025. CEO Hanna Sjöström reflects on a year marked by key milestones as we entered the clinical phase, strengthened the organization, and continued to build on our most...Neola Medical Q4 Report 2025 – Advancing IP Protection as a Core Strategic Asset across Key Markets
During the quarter four new patents were granted, adding in total of seven new patent grants during 2025. This marks Neola Medical’s strongest year to date in terms of IP protection across all key target markets – Europe, the U.S. and China. In addition,...
